Here, we review a case series of pediatric and adolescent patients, with de novo AML/MDS, harboring BCOR/BCORL1 mutations, adding to the growing body of research investigating the role of BCOR and BCORL1 mutations in pediatric myeloid malignancies. This evidence concerns the gene BCOR and myelodysplastic syndrome.